13/02/2014 - 16:25
SILVER SPRING, MD. – A Food and Drug Administration advisory panel, citing numerous problems with cangrelor’s clinical trial program, has recommended against approval of the short-acting intravenous...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology